Determinants of Metabolic Syndrome and Type 2 Diabetes in the Absence of Obesity: The Jackson Heart Study

被引:2
作者
Mongraw-Chaffin, Morgana [1 ]
Saldana, Santiago [2 ]
Carnethon, Mercedes R. [3 ]
Chen, Haiying [2 ]
Effoe, Valery [4 ]
Golden, Sherita Hill [5 ]
Joseph, Joshua [6 ]
Kalyani, Rita R. [5 ]
Bertoni, Alain G. [1 ]
机构
[1] Wake Forest Sch Med, Dept Epidemiol & Prevent, Med Ctr Blvd, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27157 USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA
[4] Morehouse Sch Med, Div Cardiol, Atlanta, GA 30310 USA
[5] Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[6] Ohio State Univ, Wexner Med Ctr, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA
关键词
type; 2; diabetes; metabolic syndrome; visceral fat normal weight; African American; BODY-MASS INDEX; CARDIOMETABOLIC RISK-FACTORS; SUBCUTANEOUS ADIPOSE-TISSUE; VISCERAL FAT; CARDIOVASCULAR-DISEASE; NORMAL-WEIGHT; AFRICAN-AMERICANS; HEALTHY OBESITY; CONSEQUENCES; ACCUMULATION;
D O I
10.1210/jendso/bvac059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Multiple studies suggest that adults who were normal weight at diabetes diagnosis are at higher risk for all-cause mortality than those who had overweight or obesity at diagnosis. Objective: While obesity is a known risk factor for cardiometabolic disease, differences in body fat distribution in those without obesity are understudied, especially in African Americans. Methods: In 1005 participants of the Jackson Heart Study, without cardiovascular disease at baseline, we used logistic regression to investigate the longitudinal association of body fat distribution by CT scan with metabolic syndrome (MetS) or type 2 diabetes (T2D). We used the harmonized International Diabetes Federation criteria to define MetS. We included only normal weight or overweight participants (BMI: 18.5 to < 30.0 kg/m(2)). We created separate models for MetS and T2D adjusted for a standard set of covariates. We excluded participants with prevalent MetS or T2D, respectively in sensitivity. Results: Higher visceral fat, subcutaneous fat, BMI, and insulin resistance (HOMA-IR) were significantly associated with MetS and T2D after adjustment. Visceral fat was strongly associated with both outcomes (MetS OR = 2.07 [1.66-2.68]; T2D OR = 1.51 [1.21-1.88]), and the association for MetS persisted in the normal weight only group. Estimates were robust to sensitivity analysis and were only modestly mediated by insulin resistance. Physical activity was not associated with MetS or T2D. Conclusion: Visceral fat is strongly associated with developing MetS, even in normal weight individuals, suggesting that excess visceral fat plays a role in cardiometabolic risk beyond that of overall adiposity and obesity in African Americans.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes
    Després, JP
    DIABETES & METABOLISM, 2003, 29 (04) : S53 - S61
  • [32] Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex
    Matsubayashi, Yasuhiro
    Fujihara, Kazuya
    Yamada-Harada, Mayuko
    Mitsuma, Yurie
    Sato, Takaaki
    Yaguchi, Yuta
    Osawa, Taeko
    Yamamoto, Masahiko
    Kitazawa, Masaru
    Yamada, Takaho
    Kodama, Satoru
    Sone, Hirohito
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [33] Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease
    Rana, J. S.
    Nieuwdorp, M.
    Jukema, J. W.
    Kastelein, J. J. P.
    DIABETES OBESITY & METABOLISM, 2007, 9 (03) : 218 - 232
  • [34] Central obesity, metabolic syndrome and type 2 diabetes mellitus
    Pusparini
    UNIVERSA MEDICINA, 2007, 26 (04) : 195 - 204
  • [35] Adiponectin expression and metabolic markers in obesity and Type 2 diabetes
    Kouidhi, S.
    Jarboui, S.
    Marrakchi, R.
    Froidevaux, M. -S. Clerget
    Seugnet, I.
    Abid, H.
    Bchir, F.
    Brahem, M.
    Demeneix, B.
    Guissouma, H.
    Elgaaied, A. Benammar
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2011, 34 (02) : E16 - E23
  • [36] Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart Study
    Davis, Sharon K.
    Gebreab, Samson Y.
    Xu, Ruihua
    Riestra, Pia
    Khan, Rumana J.
    Sumner, Anne E.
    Hickson, DeMarc
    Bidulescu, Aurelian
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [37] Genetic Susceptibility of Type 2 Diabetes and Metabolic Syndrome
    Ercegovic, Vladimir
    Dzimbeg, Monika
    Gelemanovic, Andrea
    DIABETOLOGY, 2025, 6 (02):
  • [38] Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes
    Matthew J. Gurka
    Yi Guo
    Stephanie L. Filipp
    Mark D. DeBoer
    Cardiovascular Diabetology, 17
  • [39] Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
    Tkác, I
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (01) : S2 - S9
  • [40] Stroke presentation in Type 2 diabetes and the metabolic syndrome
    Shah, Imtiaz M.
    Ghosh, Sandip K.
    Collier, Andrew
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) : E1 - E4